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In this work we analyse the relationship among in-hospital mortality and a treatment effectiveness outcome in patients affected by
ST-Elevation myocardial infarction.Themain idea is to carry out a joint modeling of the two outcomes applying a Semiparametric
Bivariate Probit Model to data arising from a clinical registry called STEMI Archive. A realistic quantification of the relationship
between outcomes can be problematic for several reasons. First, latent factors associated with hospitals organization can affect the
treatment efficacy and/or interactwith patient’s condition at admission time.Moreover, they can also directly influence themortality
outcome. Such factors can be hardly measurable. Thus, the use of classical estimation methods will clearly result in inconsistent
or biased parameter estimates. Secondly, covariate-outcomes relationships can exhibit nonlinear patterns. Provided that proper
statistical methods for model fitting in such framework are available, it is possible to employ a simultaneous estimation approach
to account for unobservable confounders. Such a framework can also provide flexible covariate structures and model the whole
conditional distribution of the response.
1. Introduction
Multiple outcomes are often used to properly characterize
an effect of interest. Nevertheless, it often happens that the
outcome of main interest is difficult or even impossible to
measure. In general, realistic quantification of the effect of a
predictor of interest on a particular response variable can be
a difficult task in statistical analysis based on observational
data. A solution is to control for confounders, that is, variables
that are associated with both covariates and response. How-
ever, important confounders may be either unknown or too
expensive to measure or not easily quantifiable (unobservable
confounders). As pointed out in [1], this problem, which is
known as endogeneity of the explanatory variable of interest,
poses serious limitations to covariate adjustment since the
use of classical techniques may yield biased and inconsistent
estimates. Further issues which deserve attention are the
possible presence of nonlinear covariate response relation-
ships and how these change when considering the whole
response variable distribution. There are many methods
in the literature that can account for confounders. These
include conditional approaches (e.g., stratification andmodel
adjustment) and marginal approaches (e.g., matching and
reweighting). For a review of these techniques see [2]. It
should be noted, however, that these techniques do not
account for unobserved confounding. Instrumental variable
techniques are widely used for isolating the effect of a given
predictor in the presence of unobserved confounding (see,
among others, [3] and references therein). They are also
increasingly used in epidemiological andmedical studies [4].
The longest established Instrumental Variable (IV) estimators
for binary outcome and treatment variables are the General-
ized Method of Moment (GMM) [5], Maximum Likelihood
(ML) [6], and Structural Mean Model (SMM) [7]. Among
theML estimators, the Recursive Bivariate (RB) probitmodel,
introduced by [1], represents an effective way to estimate the
effect that a binary regressor has on a binary outcome in
the presence of unobservables. The semiparametric version
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of BP (SBP) is an important extension since undetected
nonlinearity can have severe consequences on the estimation
of covariate effects; see [8], where an example of a penal-
ized maximum likelihood fitting procedure to estimate the
recursive bivariate probit model with nonlinear confounder-
response relationships is proposed.
The motivating problem of this work arises from the
clinical context, where multiple outcomes are often used in
order to characterize the patient’s status or the performances
of health care service with respect to patients’ management.
This is a framework where unobservable confounders are
very popular as well.
In such a context, during the last decade, the increased
capability of data collection has made available a huge
amount of information about procedures and outcomes.
More and more often multiple outcomes are measured in
order to characterize treatment effectiveness or to evalu-
ate the impact of large policy initiatives. The case study
considered in the following concerns patients affected by
ST-Elevation Myocardial Infarction (STEMI) and admitted
to any hospital of Lombardia, the Italian regional district
whose capital is Milan. Data come from a clinical registry
named STEMI Archive [9, 10], which is a result of a wider
comprehensive project (The Strategic Program “Exploitation,
integration and study of current and future health databases
in Lombardia for Acute Myocardial Infarction”).
In general, clinical registries and administrative databases
are more and more often used nowadays to answer epidemi-
ological enquiries (see [11–16], among others). The idea is to
use information collected possibly with different purposes in
order to analyze the efficacy and efficiency of the health care
system on patients’ outcomes. Thus, integrated health care
systems for data collectionmeasuringmultiple outcomes play
a fundamental role in complex clinical environments. Studies
like those reported in [13–15] focus on data arising from
REAL (Registro Angioplastiche dell’Emilia Romagna) and
SCAAR (Swedish Coronary Angiography and Angioplasty
Registry), respectively. These registries date back more than
ten years and are consequently more structured and up-to-
dated automatically with respect to STEMI Archive. Never-
theless, they are focused on the procedures (in particular, the
Angioplasty and treatment of coronary in-stent restenosis),
employed in the treatment of Acute Coronary Syndromes
as a selection criterion for including patients in the study.
Oppositely the main criterion to select eligible patients for
STEMI Archive is the pathology diagnosis, being this reg-
istry more focused on imitating the classic epidemiological
collections, though starting fromobservational data. Another
difference between STEMI Archive and other registries lies
in the collected information. In fact much organizational
information related to hospital performances is gathered in
it, in order tomonitor themain process indicators in terms of
time to intervention. Also concerning the goal of enhancing
the integration of different sources of health information that
is common to STEMI Archive, REAL, and SCAAR, STEMI
Archive aims to do it also in order to automate and streamline
clinicians’ work flow, so that data collected once can be
used multiple times for different aims. Specifically, they can
serve for measuring performances of health care systems,
for understanding how hospitals work, and for increasing
efficacy of healthcare offer in terms of costs and patterns of
care, for specific epidemiological enquires, and so on.
In STEMI Archive can be found. It consists of a clinical
collection of data related to patients admitted in all hospitals
of Regione Lombardia with STEMI diagnosis. As mentioned
before one of the innovative contents of this survey is
represented by process indicators recorded in it. They can be
used to evaluate treatment times with the aim of designing
a preferential therapeutic path to reperfusion in STEMI
patients. In this sense, this survey represents an instrument
both for epidemiological enquiries and for organizational
optimization of the cardiological health care networks, quan-
tifying the policies effects on multiple outcomes measured
at patient’s level. Within the data available from the STEMI
Archive, there are two binary outcomes of interest for the
present study: in-hospital mortality and reperfusion efficacy.
The first one indicates if a patient is discharged alive from
hospital. The second one indicates if a reduction greater than
70% of the ST-segment (The ECG signal can be divided into
different waves and segments, delimited by some relevant
points (landmarks), listed in alphabetical order starting from
letter P. The 𝑃 wave represents atrial depolarization; the
ventricular depolarization causes the QRS complex that is
followed by the ST segment.The ventricular depolarization is
responsible of the 𝑇 and the𝑈 waves. See [17], among others,
for details.) elevation in the Electrocardiographic signal has
been achieved after 1 hour from the reperfusion procedure,
that is, the primary angioplasty (Percutaneous Transluminal
Coronary Angioplasty or PTCA). These outcomes are clearly
correlated and the interest lies in their joint modelling in
order to accomplish a manyfold goal:
(1) performance evaluation (in terms of in-hospital sur-
vival) of the health care structure the patients are
admitted to;
(2) quantification of the influence of procedural variables
on outcomes: how does the management of the pat-
terns of care affect the quality of life after discharge?
(3) evaluation of the relationship between outcomes, that
is, success in reperfusion practices and mortality,
taking advantage of the jointmodeling of their depen-
dence on categorical and continuous covariates.
The paper is then organized as follows: in Section 2 we
present the recursive bivariate probit model proposed by [8],
highlighting the aspects that make such a model particularly
suitable for carrying out the analysis of STEMI Archive data;
in Section 3 the case-study is described and results of the
analysis are proposed. Section 4 contains the discussion of
results and conclusions. All the analyses have been carried out
using R software, version 3.0.2, and in particular we refer to
the R-package SemiParBIVProbit, presented in [18].
2. Recursive Bivariate Probit Model
The bivariate probit model is a natural extension of probit
regression model, where the disturbances of the two equa-
tions are assumed to be correlated in the same spirit as
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the seemingly unrelated regression model [6]. The recursive
version of the bivariate probit allows us to estimate the effect
of interest while accounting for unobserved confounders [1,
19]. The general specification is
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, 𝜀
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) are assumed to follow the
distribution N([0, 0], [1, 𝜌, 𝜌, 1]), where 𝜌 is the correlation
coefficient and the error variances are normalized to unity
since the parameters in the model can only be identified up
to a scale coefficient (e.g., [6]). To identify the parameters of
the second equation in (1), it is typically assumed that the
exclusion restriction on the exogenous variables holds. That
is, the covariates in the first equation should contain at least
one or more regressors (usually referred to as instruments)
not included in the second equation. These regressors have
to induce variation in 𝑦
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, have not to directly affect 𝑦
2𝑖
, and
have to be independent of (𝜀
1𝑖
, 𝜀
2𝑖
) given covariates. However,
as shown in [20, 21], the presence of this restriction may
not be necessary to obtain consistent estimates of the model
parameters.
Reference [8] proposed an extension of this model which
allows for flexible functional dependence of the responses on
continuous covariates: the semiparametric recursive bivariate
probit model.This extension is important because the neglect
of the presence of nonlinearitymay have severe consequences
on the estimation of covariate effects [22]. The semiparamet-
ric version of the classic bivariate probit can be written as
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corresponding parameter vector. Basis functions are typically
chosen to have convenientmathematical properties and good
numerical stability. Possible choices include B-splines, cubic
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measuring the (second-order, here) roughness of the smooth
terms in the model; that is, 𝛽T(∑2V=1∑
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parameters controlling the trade-off between fit and smooth-
ness. Given values for 𝜆V𝑘V , maximization of (4) is straight-
forward. However, smoothing parameter estimation has to be
settled in practice.This usually involves the use of specialized
numerical routines minimizing, for instance, a prediction
error criterion so that the estimated smooth functions are as
close as possible to the true functions. In the current context,
multiple smoothing parameter estimation is achieved by
minimization of the approximate unbiased risk estimator
[25]. Full computational details can be found in [8].
The inferential theory for models involving penalized
regression splines is not standard. This is because of the
presence of penalties which undermines the use of clas-
sic asymptotic results for practical modeling. Confidence
intervals (CIs) for the components in the semiparametric
bivariate probit model can be constructed using the well-
known Bayesian “confidence” intervals typically employed in
a generalized additive model context (e.g., [26, 27]). Interval
calculations are therefore based on 𝜃 | y∽̇N(?̂?,V𝜃), where
y contains the response vectors, ?̂? is the estimate of 𝜃,
and V𝜃 represents the inverse of the penalized information
matrix obtained at convergence of the algorithm. Given this
result, CIs for linear and nonlinear functions of the model
parameters can be easily obtained. Note that, for parametric
model components, using the result above is equivalent to
using classic likelihood results since such terms are not
penalized. Also, there is no contradiction in fitting model (2)
by penalized log-likelihood estimation and then constructing
CIs adopting a Bayesian approach, and such a procedure has
been employed many times in the literature (e.g., [23, 26]).
Note that in the absence of smooth functions in the
model, as in (1), classic unpenalized maximum likelihood
estimation can be reliably employed and traditional frequen-
tist results used for inference. However, it is not possible
to know whether smooth components are required before
the analysis. In fact, using a more flexible model can help
reducing the risk of misspecification due to undetected
nonlinearity, which, as mentioned earlier, can have severe
consequences on parameter estimation [22].
2.2. Average Treatment Effect. Since latent variables do not
typically havewell-defined units ofmeasurements, parameter
𝛾 in model (1) may not be interpretable. For this reason
the effect of the treatment 𝑦
1𝑖
on the response probability
𝑃(𝑦
2𝑖
= 1 | 𝑦
1𝑖
) is calculated. This can be done using the
average treatment effect (ATE; e.g., [3]). Given estimates for
the model components, the ATE can be estimated as follows:
1
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where 𝜂(𝑦1𝑖=𝑟)
2𝑖
indicates the linear predictor evaluated at
𝑟 equal to 1 or 0. The interpretation of this measure is
straightforward; it tells us how the probability of 𝑦
2𝑖
= 1
(of dying) changes if 𝑦
1𝑖
= 1 (the procedure the patient
underwent was considered effective) as compared to 𝑦
1𝑖
= 1
(the procedure was not effective).
Coefficient 𝜌 is also of interest as it is useful to ascer-
tain the presence of unobserved confounding (endogeneity).
Specifically, 𝜌 can be interpreted as the correlation between
the unobserved confounders in the two equations (e.g., [28]).
If 𝜌 = 0 then 𝜀
1𝑖
and 𝜀
2𝑖
are uncorrelated and hence there
is no problem of endogeneity. In this case, estimation of
the second equation in either (1) or (2) will yield consistent
parameter estimates. Moreover, if the model (1) or (2) was
fitted with intercepts only, it turns out that 𝜌 is precisely the
tetrachoric correlation, that is, a Pearson correlation between
two bivariate normal variables that have been observed on a
dichotomous scale [29]. CIs can be obtained using the delta
method (see [30]).
3. Case Study
In this section we present the analyses carried out fitting a
semiparametric bivariate probit model like in (2) to the data
arising from STEMI Archive, the clinical registry gathering
patients admitted with ST-segment Elevation Myocardial
Infarction diagnosis in any hospital of Regione Lombardia
district. A complete description of this clinical registry is
provided in [10], where theArchive is presented together with
the motivating clinical setting. Among the most important
patient information provided by this clinical registry, there
are as follows:
(i) mode of admission, that is, if a patient reaches the
hospital on her/his own or delivered by three different
types of rescue units of 118 (the national toll-free
number for emergencies);
(ii) demographic features, like age and sex;
(iii) clinical appearance, that is, variables describing the
patient’s status at admission. Among others, we focus
on killip class (binary variable categorizing the sever-
ity of infarction into 0 = less severe and 1 = more
severe) and Ejection Fraction (EF);
(iv) risk factors, like hypertension, diabetes, smoking, and
chronic kidney disease (CKD);
(v) times to treatment (on/off hours), times to treatment,
times to intervention, and all the process indicators
concerned with pre- and in-hospital phase (Symptom
Onset toDoor time (OD),Door to Balloon time (DB),
total ischaemic time (OB), etc.);
(vi) clinical outcomes, that is, in-hospital mortality and
treatment efficacy (STres), quantified by a reduction
of ST segment elevation in the ECG.
We focus our readings on patients who underwent primary
transluminal coronary angioplasty (PTCA), the most com-
mon reperfusion procedure for acute myocardial infarctions.
The population considered for the following analyses consists
of 1069 statistical units.
In this application, the binary outcomes of interest are
patients’ in-hospital mortality and the efficacy of the reper-
fusion treatment they undergo. The efficacy is determined
by the reduction of ST segment elevation one hour after
the surgery: if the reduction is over 70% the procedure is
Computational and Mathematical Methods in Medicine 5
considered effective. Thus it is clear why the joint modelling
of in-hospital mortality and reperfusion efficacymakes sense.
Not only are they likely to be correlated, but also a strong
clinical interest lies in quantifying the degree of correlation
among these two. Moreover, reperfusion efficacy indicator is
a binary variable whose values depend on the latent recovered
ability of the coronary arteries to work properly. So the
framework presented in [8] seems to be the proper way to
address the problem of interest.
The variable selection has been carried out according to
both clinical knowhow and the statistical stepwise approach,
similar to what is proposed in [31–34]. Then the model (2)
has been fitted to STEMI Archive data with the following
specifications:
(1) for the outcome y∗
1
(the reperfusion efficacy, STres)
we retained a binary variable (𝑥
11
) indicating if the
patient reaches the hospital on her/his own (access)
and two continuous variables (?̆?
11
and ?̆?
12
), being the
age (age) of the patient and her/his total ischaemic
time (O2B, i.e., the time between the symptom onset
and the PTCA procedure), respectively;
(2) for the outcome y∗
2
(the in-hospital mortality,
mortality) we retained a categorical variable (𝑥
21
)
indicating the patient’s killip class (killip) and a
continuous variable (?̆?
21
) measuring her/his ejection
fraction (EF) at the entrance.
Therefore, for 𝑖 = 1, . . . , 1069, model (2) becomes:
STres
∗
1𝑖
= 𝛿
10
+ 𝛿
11
× access
𝑖
+ 𝛿
12
× age
𝑖
+ 𝑠
11
(02B
1𝑖
) + 𝜀
1𝑖
,
(6a)
Mortality
∗
1𝑖
= 𝛿
20
+ 𝛿
21
× STres + 𝛿
22
× killip
+ 𝛿
23
× EF + 𝜀
2𝑖
.
(6b)
Table 1 shows the estimates provided by the bivariate probit
model for the mortality outcome ((6b), Table 1(b)) and the
indicator of successful reperfusion therapy ((6a), Table 1(a)).
It can be noticed that all the selected covariates are
significant. In particular, the treatment efficacy decreases
as the age increases, as expected. The way of admission of
patients delivered by 118 eases the good prognosis, too. It is
worth noting that the total ischaemic time effect is nonlinear,
being the smoother degrees of freedom significantly greater
than one. This confirms the clinical knowhow according to
which the way the delay affects the treatment efficacy is
definitely nonlinear [35].
Concerning themortality outcome, as expected, themore
severe the infarction (quantified by killip class), the higher the
mortality. Also a reduced ejection fraction plays the role of
increasing the mortality, as it is known by clinical practice.
The estimated correlation coefficient of the recursive
bivariate probit model is equal to 0.394 and it is significantly
different from zero at the 5% level (CI(𝜌) = (0.0637, 0.644)),
hence supporting the presence of unobserved confounders.
In fact, it is usual that a lot of unexplained variability exists in
complex healthcare processes where patterns of care consist
Table 1: Parametric and smoothed coefficients’ estimates obtained
fitting the semiparametric bivariate PROBITmodel in (2) to STEMI
Archive data.
(a) Equation (6a)
Coefficient Estimate Std. err. 𝑃 val.
intercept 𝛿
10
1.3811 0.2488 <0.0000
access 𝛿
11
0.2129 0.0933 0.0225
age 𝛿
12
−0.0088 0.0036 0.0140
Smooth term Edf Est. rank 𝑃 val.
𝑠(O2B) 𝑠
11
1.356 2 0.0041
(b) Equation (6b)
Coefficient Estimate Std. err. 𝑃 val.
intercept 𝛿
20
1.7708 0.4656 0.0001
STres 𝛿
21
−1.2480 0.2109 <0.0000
killip 𝛿
22
0.7223 0.2544 0.0045
EF 𝛿
23
−0.0748 0.0119 <0.0000
Table 2: ATE estimates obtained by fitting the semiparametric
bivariate probit and the naive approach, respectively.
ATE of Estimate CI
SBP −2.05 (−4.88, 0.77)
AP −1.92 (−20.63, 16.78)
Unadjusted −4.46 (−6.32, −2.61)
of multiple phases. It derives from the variability existing
at patient’s level plus a variability induced by the complex
process of patient’s management. Then it is crucial to find
correlations and to identify which procedures clinicians can
act upon in order to improve the process of care.
Table 2 shows ATE estimates obtained using SBP. For
completeness we also report the unadjusted estimate and
that obtained using an additive probit model (AP). AP is
a model which accounts for observed confounders but not
unobserved confounders. Under this setting ATE has been
estimated by fitting the equation of interest alone whereas the
unadjusted estimate does not account for both observed and
unobserved confounders.
It can be observed that all point estimates are negative
which is consistent with the reasoning that the better the
efficacy, the lower the mortality probability. However, the
unadjusted ATE effect is significantly greater than those
obtained using SBP and AP. This difference is due to the fact
that the former estimate does not adjust for both observed
and unobserved confounders and hence should be regarded
with suspicion. If we account for observed confounders only,
then the effect becomes strongly nonsignificant whereas the
CI of ATE changes considerably if we take into account the
unobservables. The modification of the CI seems to suggest
that with a greater number of observations, our tenet on
ATE could be confirmed. Anyway, in this case results suggest
that the presence of unobserved confounders detected by the
bivariate model may be regarded as variables which do not
6 Computational and Mathematical Methods in Medicine
interfere with the relationship of interest but whose presence
inflates the variance of the estimates.
In this study we were concerned with the possible
detrimental effect of unobserved confounders on the effect
of interest (reperfusion efficacy on mortality). Based on our
analysis, this does not seem to be an issue as the SBP andnaive
models produced similar point estimates. However, the use of
a bivariate probit model may still be preferred as it may allow
for more reliable inferences.
4. Discussion
It is more and more frequent in clinical practice that multiple
outcomes are measured for properly characterizing an effect
of interest in terms of diseases or for assessing health care
policies and performances. Nevertheless, it often happens
that (some) outcomes are difficult (even impossible) to be
measured or that confounders are difficult to be accounted
for when modeling such outcomes by means of suitable
covariates. Instrumental variables are nowadays an estab-
lished method for isolating the effect of a given predictor in
the presence of unobserved confounding.
In this work we showed an application of a semipara-
metric bivariate probit model to a couple of binary outcomes
representing the in-hospital mortality and an indicator of the
reperfusion efficacy in patients affected by acute myocardial
infarction. The efficacy is determined by the reduction of ST
segment elevation one hour after the surgery: if the reduction
is over 70% the procedure is considered effective. Data
come from a clinical registry called STEMI Archive [9]. This
case study claims for the joint modelling of the in-hospital
mortality and reperfusion efficacy outcomes. It makes sense
not only because they are likely to be correlated, but also
because a strong clinical interest lies in quantifying the
degree of correlation among these two.Moreover, reperfusion
efficacy indicator is a binary variable whose values depend on
the latent recovered ability of the coronary arteries to work
properly. In this sense, this modelling strategy represents a
step forward with respect to the results pointed out in [31]
and then in [32, 36], since a joint modelling of correlated
outcomes is possible, as well as parametric and nonpara-
metric definition of the relationship between outcomes and
covariates.
In fact there are many methods that can account for
confounders, but many of these don not account for con-
founders. This approach’s advantage over methods like Gen-
eralized Method of Moment (GMM) and Structural Mean
Models (SMM) is twofold. First, semiparametric bivariate
probit model allows for flexible functional dependence of the
response variables on continuous covariates via the use of
penalized regression splines. Unlike the classic parametric
approach typically employed in these kinds of studies, a semi-
parametric specification allows us to flexibly model the effect
of continuous covariates (e.g., the age of individuals) without
making a priori assumptions (e.g., linearity or nonlinearity
specified using quadratic or cubic polynomials).This reduces
the risk of model misspecification due to undetected non-
linearity, which can have severe consequences on parameter
estimation. Second, provided that the model assumptions
are met, identification of the treatment effect is theoretically
achieved even if an instrument is not included in the model
[20, 21]. This paper does not employ those IV techniques
for a variety of reasons. First, GMM and SMM do not
performwell if they do not have a valid instrumental variable.
More importantly, these procedures are not implemented in
software-accessible code making it difficult for practitioners
to use and interpret the results.
Results are strongly coherent with clinical practice. This
enables a better comprehension of the disease-recovery
dynamics and enables better predictions for new patients
entering the study. In general, in complex processes such
clinical ones where many sources of latent interactions may
arise, accounting and adjusting for confounders is extremely
important. This appears clearly looking at results reported in
Table 2.
In general, diagnosis and management of AMI patients
are difficult and may strongly benefit of the aid of statistical
models that provide effective risk stratification of patients. In
fact, flexible models that are able to properly profile patients
adjusting for case mix and confounders are extremely of
interest in the context of modern clinical practice, since the
more accurate predictions and more reliable prognoses that
they provide enable gaining insights of the economic burden
of AMI, supporting an effective clinical decision making.
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